Skip to main content

Table 3 Multivariate linear regression analysis of the association between dietary fatty acids and Low-frequency PTA.

From: Association between nineteen dietary fatty acids and hearing thresholds: findings from a nationwide survey

Fatty acids

Continuous

Q1

Q2

Q3

Q4

P for trend

(energy (%))

β (95% CI)

 

β (95% CI)

β (95% CI)

β (95% CI)

Total SFAs

0.04 (0.01, 0.08)*

0 (ref)

0.26 (-0.34, 0.51)

0.45 (-0.15, 1.07)

0.48 (0.14, 0.99)*

0.035

SFA 4:0

0.52 (0.02, 1.04)*

0 (ref)

0.52 (0.14, 1.16)*

0.34 (-0.02, 0.86)

0.47 (-1.06, 2.22)

0.031

SFA 6:0

0.56 (0.08, 1.61)*

0 (ref)

0.12 (-0.03, 0.35)

0.29 (-0.36, 1.23)

0.32 (-0.22, 0.89)

0.012

SFA 8:0

0.19 (-0.08, 0.45)

0 (ref)

-0.01 (-0.72, 0.58)

0.42 (0.04, 0.93)*

0.54 (-0.08, 1.10)

0.065

SFA 10:0

-0.01 (-2.00, 0.78)

0 (ref)

0.28 (-0.37, 0.93)

-0.09 (-0.74, 0.55)

-0.11 (-0.75, 0.53)

0.408

SFA 12:0

-0.01 (-0.57, 0.34)

0 (ref)

-0.03 (-0.68, 0.62)

-0.63 (-1.28, 0.01)

-0.46 (-1.10, 0.17)

0.253

SFA 14:0

-0.09 (-0.46, 0.30)

0 (ref)

0.34 (-0.31, 0.99)

-0.19 (-0.83, 0.45)

-0.13 (-0.61, 0.68)

0.398

SFA 16:0

-0.13 (0.02, 0.25)

0 (ref)

-0.23 (-0.90, 0.43)

0.26 (-0.39, 0.90)

0.43 (-0.20, 1.06)

0.078

SFA 18:0

-0.32 (-1.07, 0.55)

0 (ref)

-0.43 (-1.21, 0.07)

0.70 (0.06, 1.34)*

0.79 (0.16, 1.42)*

0.213

Total MUFAs

0.04 (-0.02, 0.10)

0 (ref)

-0.48 (-1.12, 0.17)

-0.15 (-0.79, 0.48)

0.25 (-0.38, 0.87)

0.107

MUFA 18:0

0.52 (-0.24, 1.26)

0 (ref)

0.13 (-0.52, 0.78)

0.37 (-0.27, 1.01)

0.23 (-0.40, 0.85)

0.407

MUFA 18:1

0.05 (-0.04, 0.09)

0 (ref)

-0.54 (-1.19, 0.12)

-0.17 (-0.81, 0.46)

0.28 (-0.35, 0.91)

0.188

MUFA 20:1

-1.01 (-3.10, 1.01)

0 (ref)

0.05 (-0.60, 0.68)

-0.07 (-0.70, 0.56)

0.17 (-0.46, 0.80)

0.599

MUFA 22:1

-0.57 (-4.71, 3.61)

0 (ref)

0.18 (-0.46, 0.81)

-0.12 (-0.74, 0.53)

0.26 (-0.38, 0.89)

0.469

Total PUFAs

0.06 (0.03, 0.09)*

0 (ref)

-0.38 (-1.02, 1.21)

-0.01 (-0.95, 2.31)

0.41 (-0.61, 0.65)

0.143

PUFA 18:2

0.03 (-0.05, 0.09)

0 (ref)

-0.39 (-1.03, 0.25)

-0.26 (-0.89, 0.37)

0.02 (-0.60, 0.64)

0.713

PUFA 18:3

-0.07 (-0.58, 0.41)

0 (ref)

0.03 (-0.60, 0.67)

0.03 (-0.60, 0.66)

-0.01 (-0.63, 0.62)

0.621

PUFA 18:4

-4.64 (-12.05, 5.95)

0 (ref)

0.63 (0.02, 1.25)*

0.52 (-0.10, 1.14)

0.15 (-0.49, 0.78)

0.420

PUFA 20:4

2.24 (-0.66, 4.09)

0 (ref)

-0.24 (-0.86, 0.38)

0.16 (-0.46, 0.79)

0.91 (-0.75, 3.54)

0.996

PUFA 20:5

1.12 (-0.89, 3.69)

0 (ref)

-0.22 (-0.84, 0.40)

0.10 (-0.53, 0.73)

0.80 (-1.43, 4.16)

0.050

PUFA 22:5

1.65 (0.36, 3.56)*

0 (ref)

0.17 (-0.46, 0.80)

0.07 (-0.56, 0.70)

0.67 (0.11, 1.32)*

0.023

PUFA 22:6

1.33 (0.25, 3.09)*

0 (ref)

0.06 (-0.53, 0.68)

0.21 (-0.45, 0.81)

0.94 (0.33, 2.05)*

0.015

  1. Models were adjusted for sex, age, race, education, diabetes, and energy. Continuous, Ln-transformed concentration of fatty acids; Q, quartile; 95% CI, 95% confidence interval; PTA, Pure-tone average; SFA, saturated fatty acid; MUFA, monounsaturated fatty acid; PUFA, polyunsaturated fatty acid. * indicates p < 0.05, indicating statistical significance.
Back to article page

Lipids in Health and Disease

ISSN: 1476-511X